Publication | Closed Access

Pulmonary delivery by exploiting doxorubicin and cisplatin co-loaded nanoparticles for metastatic lung cancer therapy

NanoparticlesNanomedicineEngineeringTherapeutic NanomaterialsMedicinePolymer-drug ConjugatePharmacologyPulmonary DeliveryNano-drug DeliveryTumor TargetingBiomedical EngineeringOncologyRadiation OncologyLung CancerCo-loaded Nanoparticles